To determine whether eradicating CSCs could sensitize HER2+ breast cancer to HER2-targeted therapy, Neu cells expressing SORE6-mcherry or SORE6-hTK were implanted into nude mice. This evidence concerns the gene ERBB2 and breast cancer.